T cell receptor (TCR) plays a fundamental role in adaptive immunity, and TCR-T cell therapy holds great promise for treating solid tumors and other diseases. However, there is a noticeable absence of chemical tools tuning TCR activity. In our study, we screened natural sterols for their regulatory effects on T cell function and identified 7-alpha-hydroxycholesterol (7a-HC) as a potent inhibitor of TCR signaling. Mechanistically, 7a-HC promoted membrane binding of CD3ε cytoplasmic domain, a crucial signaling component of the TCR-CD3 complex, through alterations in membrane physicochemical properties. Enhanced CD3ε membrane binding impeded the condensation between CD3ε and the key kinase Lck, thereby inhibiting Lck-mediated TCR phosphorylation. Transient treatments of TCR-T cells with 7a-HC resulted in reduced signaling strength, increased memory cell populations, and superior long-term antitumor functions. This study unveils a chemical regulation of TCR signaling, which can be exploited to enhance the long-term efficacy of TCR-T cell therapy.
Pubmed ID: 38759618 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets Annexin V
View all literature mentionsThis polyclonal targets CD247
View all literature mentionsThis monoclonal targets Phosphotyrosine 4G10 Platinum HRP Conjugate
View all literature mentionsThis polyclonal targets PLC gamma1 (1249)
View all literature mentionsThis monoclonal targets CD247
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD62L (L-Selectin)
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD45.1
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD45RA
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD62L (L-Selectin)
View all literature mentionsThis monoclonal targets TCR beta
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis unknown targets Zap-70, phospho (Tyr319) / Syk, phospho (Tyr352)
View all literature mentionsThis polyclonal targets Phospho-PLCgamma1 (Tyr783)
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis polyclonal secondary targets IgG
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD223
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD28
View all literature mentionsThis monoclonal targets CD278
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets TCR beta chain
View all literature mentionsThis monoclonal targets TCF-7/TCF-1
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets ZAP70
View all literature mentionsThis monoclonal targets CD3 zeta (phospho Y142) antibody [EP265(2)Y]
View all literature mentionsMus musculus with name C57BL/6-Tg(TcraTcrb)1100Mjb/J from IMSR.
View all literature mentions